Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Nirmal Marasini & Lisa M. Kaminskas. (2019) Subunit-based mucosal vaccine delivery systems for pulmonary delivery - Are they feasible?. Drug Development and Industrial Pharmacy 45:6, pages 882-894.
Read now
Read now
Xiaojing Dai, Jintian He, Ruxia Zhang, Guanghao Wu, Fangfang Xiong & Baohua Zhao. (2017) Co-delivery of polyinosinic:polycytidylic acid and flagellin by poly(lactic-co-glycolic acid) MPs synergistically enhances immune response elicited by intranasally delivered hepatitis B surface antigen. International Journal of Nanomedicine 12, pages 6617-6632.
Read now
Read now
Jasmine Tomar, Philip A. Born, Henderik W. Frijlink & Wouter L. J. Hinrichs. (2016) Dry influenza vaccines: towards a stable, effective and convenient alternative to conventional parenteral influenza vaccination. Expert Review of Vaccines 15:11, pages 1431-1447.
Read now
Read now
Abdelwahab Omri. (2015) Pulmonary drug and vaccine delivery: therapeutic significance and major challenges. Expert Opinion on Drug Delivery 12:6, pages 853-855.
Read now
Read now
Articles from other publishers (37)
Tosha Pandya, Prachi Joshi, Rudree Pathak & Shreeraj Shah. (2023) Nano-vaccination Strategies: Applications and Challenges for Intranasal
Immunization. Current Pharmaceutical Biotechnology 24:8, pages 946-969.
Crossref
Crossref
Kai Chen, Ning Wang, Xiaomin Zhang, Meng Wang, Yanyu Liu & Yun Shi. (2023) Potentials of saponins-based adjuvants for nasal vaccines. Frontiers in Immunology 14.
Crossref
Crossref
Xiyue He, Xiaoyan Chen, Hairui Wang, Guangsheng Du & Xun Sun. (2023) Recent advances in respiratory immunization: A focus on COVID-19 vaccines. Journal of Controlled Release 355, pages 655-674.
Crossref
Crossref
Zhuang Teng, Ling-Yang Meng, Jian-Ke Yang, Zheng He, Xi-Guang Chen & Ya Liu. (2022) Bridging nanoplatform and vaccine delivery, a landscape of strategy to enhance nasal immunity. Journal of Controlled Release 351, pages 456-475.
Crossref
Crossref
Mina Mehanny, Annette Boese, Behnoosh Bornamehr, Jessica Hoppstädter, Volker Presser, Alexandra K. Kiemer, Claus-Michael Lehr & Gregor Fuhrmann. (2022) Spray-dried pneumococcal membrane vesicles are promising candidates for pulmonary immunization. International Journal of Pharmaceutics 621, pages 121794.
Crossref
Crossref
Moein Masjedi, Talieh Montahaei, Zeinab Sharafi & Atefeh Jalali. (2022) Pulmonary vaccine delivery: An emerging strategy for vaccination and immunotherapy. Journal of Drug Delivery Science and Technology 69, pages 103184.
Crossref
Crossref
M. Munir, L. Jena, V.L. Kett, N.J. Dunne & H.O. McCarthy. (2022) Spray drying: Inhalable powders for pulmonary gene therapy. Biomaterials Advances 133, pages 112601.
Crossref
Crossref
Ruonan Su, Yu Zhang, Jiabin Zhang, Haixia Wang, Yun Luo, Hon Fai Chan, Yu Tao, Zhuanggui Chen & Mingqiang Li. (2021) Nanomedicine to advance the treatment of bacteria-induced acute lung injury. Journal of Materials Chemistry B 9:44, pages 9100-9115.
Crossref
Crossref
Penghao Zhang, Lulu Huang, En Zhang, Chen Yuan & Qian Yang. (2021) Oral administration of Bacillus subtilis promotes homing of CD3+ T cells and IgA-secreting cells to the respiratory tract in piglets. Research in Veterinary Science 136, pages 310-317.
Crossref
Crossref
Zimei Wu & Tonglei Li. (2021) Nanoparticle-Mediated Cytoplasmic Delivery of Messenger RNA Vaccines: Challenges and Future Perspectives. Pharmaceutical Research 38:3, pages 473-478.
Crossref
Crossref
Margot Savoy. (2020) What’s New in Vaccine Science. Primary Care: Clinics in Office Practice 47:3, pages 517-528.
Crossref
Crossref
Elham Darzi Eslam, Shakiba Darvish Alipour Astaneh, Iraj Rasooli, Shahram Nazarian & Abolfazl Jahangiri. (2020) Passive immunization with chitosan-loaded biofilm-associated protein against Acinetobacter baumannii murine infection model. Gene Reports 20, pages 100708.
Crossref
Crossref
Mario Fragoso‐Saavedra & Marco A. Vega‐López. (2020) Induction of mucosal immunity against pathogens by using recombinant baculoviral vectors: Mechanisms, advantages, and limitations. Journal of Leukocyte Biology 108:3, pages 835-850.
Crossref
Crossref
Hesam Karimi, Hoorieh Soleimanjahi, Asghar Abdoli & Razieh Sadat Banijamali. (2020) Combination therapy using human papillomavirus L1/E6/E7 genes and archaeosome: a nanovaccine confer immuneadjuvanting effects to fight cervical cancer. Scientific Reports 10:1.
Crossref
Crossref
Leah M. Johnson, Jeffrey B. Mecham, Frederick Quinn & Anthony J. Hickey. (2020) Nanoparticle Technology for Respiratory Tract Mucosal Vaccine Delivery. KONA Powder and Particle Journal 37:0, pages 97-113.
Crossref
Crossref
Miao Li, Yi Wang, Yuan Sun, Hongyu Cui, Shu J. Zhu & Hua-Ji Qiu. (2020) Mucosal vaccines: Strategies and challenges. Immunology Letters 217, pages 116-125.
Crossref
Crossref
Joon Haeng Rhee. 2020. Mucosal Vaccines. Mucosal Vaccines
325
356
.
Aneesh Thakur & Camilla Foged. 2020. Nanoengineered Biomaterials for Advanced Drug Delivery. Nanoengineered Biomaterials for Advanced Drug Delivery
603
646
.
Yun Yang, Li Chen, Hong-wu Sun, Hong Guo, Zhen Song, Ying You, Liu-yang Yang, Ya-nan Tong, Ji-ning Gao, Hao Zeng, Wu-chen Yang & Quan-ming Zou. (2019) Epitope-loaded nanoemulsion delivery system with ability of extending antigen release elicits potent Th1 response for intranasal vaccine against Helicobacter pylori. Journal of Nanobiotechnology 17:1.
Crossref
Crossref
Cynthia Calzas & Christophe Chevalier. (2019) Innovative Mucosal Vaccine Formulations Against Influenza A Virus Infections. Frontiers in Immunology 10.
Crossref
Crossref
Farzad Khademi, Mohammad Derakhshan, Arshid Yousefi-Avarvand, Adel Najafi & Mohsen Tafaghodi. (2018) A novel antigen of Mycobacterium tuberculosis and MPLA adjuvant co-entrapped into PLGA:DDA hybrid nanoparticles stimulates mucosal and systemic immunity. Microbial Pathogenesis 125, pages 507-513.
Crossref
Crossref
Petra Bacher & Alexander Scheffold. (2018) The effect of regulatory T cells on tolerance to airborne allergens and allergen immunotherapy. Journal of Allergy and Clinical Immunology 142:6, pages 1697-1709.
Crossref
Crossref
Petra Bacher & Alexander Scheffold. (2018) Antigen-specific regulatory T-cell responses against aeroantigens and their role in allergy. Mucosal Immunology 11:6, pages 1537-1550.
Crossref
Crossref
Sung Kang, Seok Hong, Yong-Kyu Lee & Sungpil Cho. (2018) Oral Vaccine Delivery for Intestinal Immunity—Biological Basis, Barriers, Delivery System, and M Cell Targeting. Polymers 10:9, pages 948.
Crossref
Crossref
M. van Splunter, E. van Hoffen, E.G. Floris-Vollenbroek, H. Timmerman, E Lucas-van de Bos, B. Meijer, L.H. Ulfman, B. Witteman, J.M. Wells, S. Brugman, H F J Savelkoul & R J J van Neerven. (2018) Oral cholera vaccination promotes homing of IgA+ memory B cells to the large intestine and the respiratory tract. Mucosal Immunology 11:4, pages 1254-1264.
Crossref
Crossref
Blaise Corthésy & Gilles Bioley. (2018) Lipid-Based Particles: Versatile Delivery Systems for Mucosal Vaccination against Infection. Frontiers in Immunology 9.
Crossref
Crossref
Hidehiko Suzuki, Takahiro Nagatake, Ayaka Nasu, Huangwenxian Lan, Koji Ikegami, Mitsutoshi Setou, Yoko Hamazaki, Hiroshi Kiyono, Kiyohito Yagi, Masuo Kondoh & Jun Kunisawa. (2018) Impaired airway mucociliary function reduces antigen-specific IgA immune response to immunization with a claudin-4-targeting nasal vaccine in mice. Scientific Reports 8:1.
Crossref
Crossref
Rachel Gaul, Joanne M. Ramsey, Andreas Heise, Sally-Ann Cryan & Catherine M. Greene. 2018. Design of Nanostructures for Versatile Therapeutic Applications. Design of Nanostructures for Versatile Therapeutic Applications
221
253
.
Shahid Sukhbir Kaur. (2017) Pulmonary drug delivery system: newer patents. Pharmaceutical Patent Analyst 6:5, pages 225-244.
Crossref
Crossref
Daniella Calderon-Nieva, Kalhari Bandara Goonewardene, Susantha Gomis & Marianna Foldvari. (2017) Veterinary vaccine nanotechnology: pulmonary and nasal delivery in livestock animals. Drug Delivery and Translational Research 7:4, pages 558-570.
Crossref
Crossref
I. Saleem, K. Petkar & S. Somavarapu. 2017. Micro and Nanotechnology in Vaccine Development. Micro and Nanotechnology in Vaccine Development
357
371
.
Nattika Nantachit, Panya Sunintaboon & Sukathida Ubol. (2016) Responses of primary human nasal epithelial cells to EDIII-DENV stimulation: the first step to intranasal dengue vaccination. Virology Journal 13:1.
Crossref
Crossref
Marianna Foldvari, Ding Wen Chen, Nafiseh Nafissi, Daniella Calderon, Lokesh Narsineni & Amirreza Rafiee. (2016) Non-viral gene therapy: Gains and challenges of non-invasive administration methods. Journal of Controlled Release 240, pages 165-190.
Crossref
Crossref
Sharan Bobbala & Sarah Hook. (2016) Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?. Pharmaceutical Research 33:9, pages 2078-2097.
Crossref
Crossref
V. Ilic, V. Dunet, A. Le Pape, M. Buchs, M. Kosinski, A. Bischof Delaloye, S. Gerber & J. O. Prior. (2016) SPECT/CT study of bronchial deposition of inhaled particles. Nuklearmedizin 55:5, pages 203-208.
Crossref
Crossref
Takato Kusakabe, Koji Ozasa, Shingo Kobari, Masatoshi Momota, Natsuko Kishishita, Kouji Kobiyama, Etsushi Kuroda & Ken J. Ishii. (2016) Intranasal hydroxypropyl-β-cyclodextrin-adjuvanted influenza vaccine protects against sub-heterologous virus infection. Vaccine 34:27, pages 3191-3198.
Crossref
Crossref
Kai Schulze, Thomas Ebensen, Peggy Riese, Blair Prochnow, Claus-Michael Lehr & Carlos A. Guzmán. 2016. How to Overcome the Antibiotic Crisis. How to Overcome the Antibiotic Crisis
207
234
.